New Monthly AEFI Report Out as of 30 Nov 2022. 168,816,023 Doses. 73,607,140 Filipinos Fully Jabbed. 20,750,044 Boosted. 111,046 Reports of Adverse Reactions, 10,341 Serious. 2,760 Deaths!

2.59 million new doses in November 2022. Downwards correction on vaccine doses for Coronavac, Astrazeneca, Moderna, Sinopharm. Hospitalization up to 4.3/100,000 doses. DOH submit agreements to COA.

Updated Adverse Reaction Report as of 30 November 2022 just released! 394,158 doses of covid-19 vaccine were reported as injected in November 2022, an average of 13,139 doses a day (Cf. 52,245 doses/day in October 2022). There was some downward adjustment (corrections?) of vaccine dosing for some brands (-AstraZeneca = -73,054, Moderna = - 111,240, Sinopharm = -2,288).

The vaccines are still officially considered by authorities to have positive benefit-risk balance, regardless that 2,760 persons are reported dead following receipt, and there are 11,046 reports of adverse reactions, including 10,341 serious. Rates of hospitalization have increased to 4.3/100,000 doses from the prior month’s 4.24. The average age of the reported deaths dropped slightly to 59.22, from 59.26 in October 2022.

The deaths and adverse reactions are still blamed on comorbidities.

Doses and adverse reactions are shown. It clearly doesn’t matter what is reported, the safe and effective message will continue!

Breakdown of reported deaths by ages is shown.

Adverse reactions are surely grossly underreported. I am in contact with the CDCPH medical and legal teams and we are aware that most victims of adverse reactions (or their surviving families) decline to report any reaction, even when a plausible temporal link to the adverse outcome exists.

Dose of vaccines are still trending downwards, despite the DOH’s efforts and particularly their targeting of the school children in early December 2022.

In other news, DOH has submitted their vaccine procurement documents to the Commission on Audit. I will be watching for any public updates on this.

The Covid-19 Vaccines never were free, they came with a cost. Based on indicative market pricing, the partial costing for the jabs used, excluding Jansen and Sinopharm, and Novovax (not been used in Philippines yet), is about PHP 217.6 billion.

How does this compare to the Philippines overall budget? The 2023 budget has just been approved at PHP5.2 trillion, the largest ever budget by any Philippines Government to date (the 2022 budget was PHP5.024 trillion, while the 2021 budget was PHP4.506 trillion).

The market cost of the Covid-19 Vaccines relative to the 2023 budget is 4.13%. 4.13% for a product that is now being proved internationally to harm more than help, and with lasting and reverberating adverse repercussions, only starting to come to broader public awareness.

DOH has indicated that it will be procuring Bivalent Covid-19 Vaccines, just as soon as FDA has issued EUA on these items.

Now this statement with regards to FDA approval of bivalent vaccines is curious indeed, because I have firsthand knowledge that the DOH is already offering and injecting bivalent covid-19 Vaccines in Manila. It would appear that the bivalent vaccines are already being offered even without an EUA in place? What are the ethical and legal implications of this?

Current wastage of vaccines doses is estimated at 44 million doses.

Vaccination achievements, indeed! Pray for the people of the Philippines! Many are still being forced to accept these products!